Association analysis of apoptosis-related gene Caspase3, integrin α subunit 1 and glutathione sulfur transferase M1 gene polymorphisms and susceptibility to gastric cardia carcinoma
Abstract
Objective: To explore the association of polymorphisms of apoptosis-linked genes caspase3 (CASP3), integrin α subunit 1 (ITGA1), glutathione sulfur transferase M1 (GSTM1) with susceptibility to gastric cardia carcinoma (GCC).
Methods: From February 2016 to March 2018, selection of 113 GCC patients was as the gastric cancer (GC), and selection of 75 patients without gastric disease was as the control. Detection of CASP3, ITGA1 and GSTM1 gene polymorphisms in patients’ peripheral blood was to analyze their association with GC. Division of the GC was into the good prognosis and the unpleasing prognosis in the light of the survival of patients after surgery of 3 years, and the predictable value of gene polymorphisms of CASP3, ITGA1 and GSTM1 in GCC patients was analyzed.
Results: CASP3 gene rs12108497 locus, ITGA1 gene rs1862610 locus and GSTM1 genotype of the GC and the control were in accord with Hardy-Weinberg equilibrium (P > 0.05); The detection rate of CASP3 gene rs12108497 locus TC/CC type, ITGA1’s gene rs1862610 locus AC/AA type and GSTM1 blank type in the GC was elevated vs. the control (P < 0.05); Logistic regression analysis manifested smoking, anxiety, helicobacter pylori infection, family history of gastrointestinal tumor, combination with chronic gastric disease, CASP3 gene and GSTM1 gene polymorphism were risk factors for GC (P < 0.05); Stratification was in the light of individual smoking status, discovering that the detection rates of CASP3 gene rs12108497 locus TC/CC type, ITGA1 gene RS1862610 locus AC/AA type and GSTM1 blank type in the smoking were crucially augmented vs. the smoking (P < 0.05); The detection rates of CASP3 gene rs12108497 locus TC/CC type, ITGA1 gene rs1862610 locus AC/AA type and GSTM1 blank type in the death were augmented vs. the survival (P < 0.05); Combined detection of CASP3, ITGA1 and GSTM1 gene polymorphisms was provided with predictive value for GCC’s prognosis (P < 0.05).
Conclusion: CASP3 and GSTM1 genes are susceptibility genes for GCC, which might be associated with the occurrence of GCC in smoking patients, and the joint detection of multiple genes is provided with predictive value for patients’ prognosis.
References
[2]Zhao X, Dai D, Li X, et al. A polymorphism within the mismatch repair gene predicts prognosis and adjuvant chemotherapy benefit in gastric cancer[J]. Gastric Cancer, 2019, 22(6):1121-1129.
[3] Xiaofang Wu, Fang Yin, Yingfen Wu, et al. Risk of gastric cancer in patients with Helicobacter pylori infection and TP53 gene polymorphism [J]. Chinese Journal of Nosocomiology, 2021, 31(9): 4.
[4] Licong Ma, Xuyang Tian, Xingyu Wang, et al. Association analysis of SNPs in YAP gene with the infection of Helicobacter pylori and non-cardia gastric cancer [J]. Acta Universities Medicinalis Anhui , 2021, 56(9):5.
[5] Qingsong Zhang, Chuanwei Zhu, Sanliu Wang, et al. Susceptibility of polymorphisms in integrins to risk of gastric cancer [J]. The Journal of Practical Medicine, 2019, 35(8):6.
[6] National Health and Family Planning Commission of the People's Republic of China Guidelines for standardized diagnosis and treatment of gastric cancer (trial)[J]. Chin J Med Front, 2013, (8):56-63.
[7]Gonzalez RS, Cates JMM, Revetta F, et al. Gastric Carcinomas With Lymphoid Stroma: Categorization and Comparison With Solid-Type Colonic Carcinomas[J]. Am J Clin Pathol, 2017, 148(6):477-484.
[8]Guo X, Dong Z, Yamada S, et al. Association of Casp3 microRNA Target Site (1049216) SNP With the Risk and Progress of Cervical Squamous Cell Carcinoma[J]. Int J Gynecol Cancer, 2017, 27(2):206-213.
[9]Yu Z, Yu W, Liu J, et al. Lens-specific deletion of the Msx2 gene increased apoptosis by enhancing the caspase-3/caspase-8 signaling pathway.[J]. J Int Med Res, 2018, 46(7):2843-2855.
[10]Wu Y, Ni J, Qi M, et al. Associations of genetic variation in CASP3 gene with noise-induced hearing loss in a Chinese population: a case–control study[J]. Environ Health, 2017, 16(1):78-79.
[11]Shahrokhzadeh S, Soleimani A, Kordi-Tamandani DM, et al. Association of Genetic Polymorphisms in GSTP1, GSTM1, and GSTT1 Genes with Vesicoureteral Reflux Susceptibility in the Children of Southeast Iran[J]. Iran J Public Health, 2020, 49(7):1364-1371.
[12]Carron J, Lopes-Aguiar L, Costa EFD, et al. GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation[J]. Basic Clin Pharmacol Toxicol, 2017, 121(6):520-525.
[13] Jing Lu, Xingyang Yi, Jie Li, et al. Inflammation and endothelial function relevant genetic polymorphisms and carotid plaque [J]. Chinese Journal of Neurology, 2020, 53(10):763-771.
[14]Miao X, Deng Z, Wang S, et al. IAP-1 promoted cisplatin resistance in nasopharyngeal carcinoma via inhibition of caspase-3-mediated apoptosis[J]. Am J Cancer Res, 2021, 11(3):640-667.
[15]Shamloo HB, Shahabi A, Aghazadeh Z, et al. Pichia fermentans originates apoptosis in human oral squamous cell carcinoma by over-expressing BAX and CASP 9 genes[J]. Cytotechnology, 2020, 72(3):445-454.
[16]Zakiullah -, Saeed M, Javed N, et al. Association of nasopharyngeal cancer risk with genetic polymorphisms of drug-metabolizing enzyme genes GSTM1, GSTT1 andCYP1A1 (rs4646903 variant), in tobacco addicted patients of Pashtun Ethnicity of Khyber Pakhtunkhwa province of Pakistan[J]. Pak J Pharm Sci, 2019, 32(5):2107-2116.
[17]Yang DL, Dong LF, Qiu YB, et al. An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction[J]. Neoplasma, 2021, 68(5):1052-1062.
[18] Li Yuan, Liwei Zhang, Limian Er, et al. Research on genetic susceptibility of Bcl-2 gene polymorphism to gastric cardiac carcinoma and precancerous lesions in population with high incidence of esophageal cancer [J]. Chinese Journal of Cancer Prevention and Treatment, 2019, 26(22):6.
[19]Hidaka A, Sasazuki S, Matsuo K, et al. CYP1A1,GSTM1andGSTT1genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study[J]. Int J Cancer, 2016, 139(4):759–768.
[20] Fang Gao, Licong Ma, Wenjie Dong, et al. Analysis on association between single nucleotide polymorphisms of ITGA1 gene and risk of non-cardia gastric cancer [J]. Journal of Jilin University: Medical Edition, 2019, 045(003):577-581.
[21] Xiaohan Liu, Li Li, Jie Ji, et al. Meta-analysis on the association of GSTM1 gene polymorphism with head and neck cancer susceptibility in Chinese population [J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2020, 27(1):6.
[22]Barańska M, Rychlik-Sych M, Skrętkowicz J, et al. Analysis of genetic polymorphisms of glutathione S‐transferase (GSTP1, GSTM1, and GSTT1) in Polish patients with systemic sclerosis[J]. Int J Rheum Dis, 2019, 22(12):2119-2124.
[23]Zhang J, Wu Y, Hu X, et al. GSTT1, GSTP1, and GSTM1 genetic variants are associated with survival in previously untreated metastatic breast cancer[J]. Oncotarget, 2017, 8(62):105905-105914.
[24]Zhao F, Su JF, Lun SM, et al. Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a highincidence area of northern China[J]. Oncol Lett, 2019, 18(2):1267-1277.
Copyright (c) 2022 Rui Wang, Zetian Zhang, Duo Li, Na Wu, Zhao Peng
This work is licensed under a Creative Commons Attribution 4.0 International License.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.